Literature DB >> 702058

Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

G Lavie, D Zucker-Franklin, E C Franklin.   

Abstract

Peripheral blood monocytes incubated in a serum-free medium degraded serum amyloid A (SAA) protein along three pathways. Of 20 normal subjects, 8 degraded SAA completely with no detectable intermediates. Eight subjects transiently produced an amyloid A (AA)-like intermediate which comigrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) with tissue AA protein and reacted with antisera to AA, whereas four subjects yielded a persistent AA-like intermediate on PAGE. This group also failed to degrade tissue AA protein. Cells from 10 patients with amyloidosis fell into the second group. The responsible enzymes appear to be serine proteases because they are inhibited by disopropyl fluorophosphate. They were not affected by epsilon-amino caproic acid, L-1-tosylamide-2-phenylethyl chloromethyl ketone, or N-alpha-p-tosyl-L-lysine chlormethyl ketone. It appears possible that the enzymes are associated with the outer membrane of the cell because only a small fraction of the activity is secreted into the medium and because enzyme activity remains after fixation of the cells with glutaraldehyde which completely stops phagocytosis. Perhaps differences in patterns of proteolysis may play a role in the predisposition to amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702058      PMCID: PMC2185017          DOI: 10.1084/jem.148.4.1020

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  SEPARATION OF WHITE BLOOD CELLS.

Authors:  A BOYUM
Journal:  Nature       Date:  1964-11-21       Impact factor: 49.962

2.  Characterization of the ribosome-protected regions of 125I-labelled rabbit globin messenger RNA.

Authors:  S Legon
Journal:  J Mol Biol       Date:  1976-09-05       Impact factor: 5.469

3.  Aminopeptidase on the surface of differentiating macrophages: induction and characterization of the enzyme.

Authors:  E D Wachsmuth; J P Stoye
Journal:  J Reticuloendothel Soc       Date:  1977-11

4.  The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the VlambdaI subclass.

Authors:  R P Linke; F W Tischendorf; D Zucker-Franklin; E C Franklin
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

5.  Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.

Authors:  G G Glenner; W Terry; M Harada; C Isersky; D Page
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

6.  Transformation of monocytes into "fat" cells.

Authors:  D Zucker-Franklin; G Grusky; A Marcus
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

7.  A cytotoxic proteinase isolated from human lymphocytes.

Authors:  V B Hatcher; M S Oberman; G S Lazarus; A I Grayzel
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

8.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Characterization of an amyloid fibril protein from senile cardiac amyloid.

Authors:  P Westermark; J B Natvig; B Johansson
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.

Authors:  B U Wintroub; E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  37 in total

1.  Antigenic competition between dengue and Coxsackie viruses for presentation to B cells by macrophages.

Authors:  N Rizvi; U C Chaturvedi; A Mathur
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

2.  Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production.

Authors:  A F Strachan; E G Shephard; D U Bellstedt; G A Coetzee; D R van der Westhuyzen; F C de Beer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature.

Authors:  Adarsh Babu; Helen Lachmann; Tom Pickett; Preetham Boddana; Linmarie Ludeman
Journal:  CEN Case Rep       Date:  2013-08-09

Review 4.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

Review 5.  Reactive (secondary) amyloidosis and its pathogenesis.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.

Authors:  P R Hol; A M van Ederen; F W Snel; J P Langeveld; J H Veerkamp; E Gruys
Journal:  Br J Exp Pathol       Date:  1985-06

7.  A T-cell response to the anti-arthritic drug penicillamine in the mouse: requirements for generation of the drug-derived antigen.

Authors:  C A O'Donnell; J W Coleman
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

8.  Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis.

Authors:  F C de Beer; A E Nel; R P Gie; P R Donald; A F Strachan
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

9.  Secondary amyloidosis in a bull with Chediak-Higashi syndrome.

Authors:  G L Burns; K M Meyers; D J Prieur
Journal:  Can J Comp Med       Date:  1984-01

10.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.